Colorectal cancer starts in the colon (large intestine) or rectum. The risk of colorectal cancer goes up as you get older (90% of cases occur in people over 50), and if you eat a meat-heavy diet, smoke, or have a family history of the cancer. Colorectal cancer symptoms include pain, blood in the stool, and a change in bowel habits. Routine screening for colorectal cancer is recommended starting at age 50or even sooner for those with risk factors.
Colorectal Cancer News
MONDAY, Sept. 8, 2014 (HealthDay News) — Having prediabetes may increase a person’s risk for cancer, researchers report. The researchers analyzed 16 studies that included nearly 900,000 people from around the world and found that people with prediabetes had a 15 percent overall increased risk of cancer. People with prediabetes have blood sugar levels that are [...]
By Dennis ThompsonHealthDay Reporter WEDNESDAY, Aug. 27, 2014 (HealthDay News) — Doctors may be performing too many repeat colonoscopies on people who’ve had pre-cancerous polyps removed during an earlier colon cancer screening, a new Norwegian study suggests. Many of these patients have no greater risk of dying from colon cancer than the general public, the researchers determined. [...]
By Steven ReinbergHealthDay Reporter MONDAY, Aug. 18, 2014 (HealthDay News) — Older people who aren’t expected to live more than 10 years are still being screened for prostate, breast, cervical and colon cancer — even though it is unlikely to benefit them, a new study finds. Unnecessary screening can lead to invasive procedures, such as biopsies, and [...]
By Amy NortonHealthDay Reporter TUESDAY, Aug. 12, 2014 (HealthDay News) — Colon cancer screening done by sigmoidoscopy — a less invasive, cheaper alternative to colonoscopy — does cut people’s risk of developing or dying from the disease, a new clinical trial finds. Experts said the study, conducted in Norway and reported in the Aug. 13 issue of [...]
The U.S. Food and Drug Administration on Monday approved a new at-home, DNA-based stool test that screens for colorectal cancer with more than 90 percent accuracy.